EPHX1 gene polymorphisms and individual susceptibility to lung cancer

Cancer Lett. 2006 Jun 8;237(1):102-8. doi: 10.1016/j.canlet.2005.05.029. Epub 2005 Jul 7.

Abstract

We investigated the roles of EPHX1 Tyr113His and His139Arg polymorphisms in lung cancer susceptibility in a Finnish study population comprising of 230 lung cancer cases and a large control group (n=2105). The controls were distributed into five age strata, which enabled us to examine the potential age-related changes in the putative EPHX1 at-risk genotypes in the cancer free population. Although the exon 3 slow activity associated allele (His113) containing genotypes posed a decreased lung cancer risk compared with the homozygous wild-type Tyr113/Tyr113 genotype (OR, 0.68; 95% CI, 0.49-0.94), no association was seen for the EPHX1 phenotypes interpreted from the combined exons 3 and 4 genotype data. Neither was any difference seen in the prevalence of the EPHX1 Tyr113His genotypes or interpreted EPHX1 phenotypes in the different age groups.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Epoxide Hydrolases / genetics*
  • Female
  • Finland
  • Gene Expression Regulation, Neoplastic*
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Lung Neoplasms / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Risk Factors
  • Smoking

Substances

  • Epoxide Hydrolases